COVID-19 can cause ‘face blindness,’ research finds
COVID-19 can cause difficulty recognizing faces and navigational problems, according to a new study by researchers at Dartmouth College.
It is widely known that COVID-19...
Long COVID is linked to physical inactivity, study finds
The link between symptoms of COVID-19 and physical inactivity is increasingly evident.
A new study by researchers at the University of São Paulo found that...
Who is most at risk for long COVID?
A new Harvard study of more than 800,000 people in the US has provided valuable insights into the demographics and clinical profiles of those...
This new drug widely efficient in COVID-19 treatment, study finds
A team of scientists from the University of Cambridge and other institutions have discovered a compound that could be effective in treating different variants...
Scientists find new drugs preventing resistant COVID-19 variants
COVID-19 is caused by the SARS-CoV-2 virus, which has undergone various mutations resulting in the emergence of different variants.
These variants have different genetic sequences...
Long COVID is much less likely after omicron than after initial variant
In a study from Cantonal Hospital St. Gallen and elsewhere, scientists found the omicron variant of SARS-CoV-2 is much less likely to lead to...
Long COVID is much less likely after omicron than after initial variant
In a study from Cantonal Hospital St. Gallen and elsewhere, scientists found the omicron variant of SARS-CoV-2 is much less likely to lead to...
COVID-19 infections increase risk of long-lasting gut problems
A new study has found that people who have had COVID-19 are at a higher risk of gastrointestinal (GI) disorders within a year of infection.
Common eye disease in older people may increase risk of severe COVID-19
According to recent studies, age-related macular degeneration (AMD) is a clinical risk factor for increased risks of infection and death.
Furthermore, it has been reported...
“COVID rebound” is surprisingly common, study finds
Researchers at Scripps Research and digital health company eMed have reported preliminary findings from an ongoing study of people who order SARS-CoV-2 antigen test...